2015
Defeating AIDS—advancing global health
Piot P, Karim S, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E, Watts C, Kilonzo N, McManus J, Sidibé M, Commission U. Defeating AIDS—advancing global health. The Lancet 2015, 386: 171-218. PMID: 26117719, DOI: 10.1016/s0140-6736(15)60658-4.Peer-Reviewed Original ResearchAcquired Immunodeficiency SyndromeBiomedical ResearchEpidemicsEvidence-Based MedicineGlobal HealthHealth Care CostsHumansPatient ParticipationFunding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries
Resch S, Ryckman T, Hecht R. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries. The Lancet Global Health 2015, 3: e52-e61. PMID: 25539970, DOI: 10.1016/s2214-109x(14)70342-0.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAfrica South of the SaharaDeveloping CountriesFinancial SupportHealth ExpendituresHealth Services Needs and DemandHIV InfectionsHumansInternational CooperationConceptsDomestic spendingRecipient country governmentsLow-income countriesCapacity of countriesEconomic growthDomestic expenditureHealth spendingCountry governmentsFinancing requirementsFunding gapFinancial agreementsFunding requirementsSpendingDonor fundsMiddle-income countriesIncome countriesDomestic sourcesNational governmentsDonor supportCountriesDonor contributionsNational prioritisationAvailable fundingGovernmentFunding partners
2011
Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, Hecht R, Atun R. Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries. PLOS ONE 2011, 6: e25310. PMID: 21998648, PMCID: PMC3187775, DOI: 10.1371/journal.pone.0025310.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAnti-HIV AgentsChildCost-Benefit AnalysisDeveloping CountriesEmploymentHumansIncomeInvestmentsTime FactorsConceptsMiddle-income countriesAIDS treatmentProgram costsIncome countriesLarge health gainsAntiretroviral therapyHIV infectionOpportunistic infectionsGlobal FundLife careMedical treatmentAIDS diseaseTreatment programHealth gainsCurrent cohortTotal program costsTreatmentPatientsCohortInfectionCareEnd 2011Same periodEconomic benefitsLabor productivity effects
2010
Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31
Hecht R, Stover J, Bollinger L, Muhib F, Case K, de Ferranti D. Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31. The Lancet 2010, 376: 1254-1260. PMID: 20934597, DOI: 10.1016/s0140-6736(10)61255-x.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAnti-Retroviral AgentsChildDeveloping CountriesHealth ExpendituresHealth PolicyHIV InfectionsHIV-1HumansInternational CooperationPrevalenceConceptsMiddle-income countriesLong-term funding needsLow-income countriesHIV/AIDS fundingOutside fundsPolicy choicesFunding needsStrategic investmentsEfficiency gainsEfficient mobilisationRepresentative countriesAIDS fundingCountriesFundsRange of scenariosShort termGlobal HIV/AIDS pandemicHIV/AIDS programsCostHIV/AIDS responseManagement of resourcesSubstantial variationFinancingInvestmentHIV/AIDS
2009
Critical Choices In Financing The Response To The Global HIV/AIDS Pandemic
Hecht R, Bollinger L, Stover J, McGreevey W, Muhib F, Madavo CE, de Ferranti D. Critical Choices In Financing The Response To The Global HIV/AIDS Pandemic. Health Affairs 2009, 28: 1591-1605. PMID: 19887401, DOI: 10.1377/hlthaff.28.6.1591.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdultCosts and Cost AnalysisDeveloping CountriesGlobal HealthHealth Care CostsHealth PolicyHealth Services AccessibilityHIV InfectionsHumansMiddle AgedPandemicsYoung Adult